nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0403	0.0736	CbGbCtD
Tretinoin—CYP3A7—Simvastatin—atherosclerosis	0.0403	0.0736	CbGbCtD
Tretinoin—CYP3A7—Lovastatin—atherosclerosis	0.0394	0.072	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0394	0.072	CbGbCtD
Tretinoin—CYP2B6—Simvastatin—atherosclerosis	0.0384	0.0701	CbGbCtD
Tretinoin—CYP3A5—Rosuvastatin—atherosclerosis	0.0325	0.0594	CbGbCtD
Tretinoin—CYP3A5—Simvastatin—atherosclerosis	0.0302	0.0552	CbGbCtD
Tretinoin—CYP3A5—Lovastatin—atherosclerosis	0.0296	0.054	CbGbCtD
Tretinoin—CYP3A5—Pravastatin—atherosclerosis	0.0296	0.054	CbGbCtD
Tretinoin—CYP2C8—Simvastatin—atherosclerosis	0.0291	0.0531	CbGbCtD
Tretinoin—CYP2C8—Lovastatin—atherosclerosis	0.0284	0.0519	CbGbCtD
Tretinoin—CYP2C8—Pravastatin—atherosclerosis	0.0284	0.0519	CbGbCtD
Tretinoin—CYP2C9—Rosuvastatin—atherosclerosis	0.0218	0.0398	CbGbCtD
Tretinoin—CYP2C9—Simvastatin—atherosclerosis	0.0203	0.037	CbGbCtD
Tretinoin—CYP2C9—Pravastatin—atherosclerosis	0.0198	0.0362	CbGbCtD
Tretinoin—CYP2C9—Lovastatin—atherosclerosis	0.0198	0.0362	CbGbCtD
Tretinoin—CYP3A4—Ezetimibe—atherosclerosis	0.0127	0.0231	CbGbCtD
Tretinoin—CYP3A4—Rosuvastatin—atherosclerosis	0.0127	0.0231	CbGbCtD
Tretinoin—CYP3A4—Simvastatin—atherosclerosis	0.0118	0.0215	CbGbCtD
Tretinoin—CYP3A4—Lovastatin—atherosclerosis	0.0115	0.0211	CbGbCtD
Tretinoin—CYP3A4—Pravastatin—atherosclerosis	0.0115	0.0211	CbGbCtD
Tretinoin—RARRES1—adipose tissue—atherosclerosis	0.00163	0.0659	CbGeAlD
Tretinoin—CRABP1—connective tissue—atherosclerosis	0.00157	0.0636	CbGeAlD
Tretinoin—CRABP2—connective tissue—atherosclerosis	0.00142	0.0575	CbGeAlD
Tretinoin—ALDH1A2—cardiovascular system—atherosclerosis	0.00142	0.0573	CbGeAlD
Tretinoin—ALDH1A2—adipose tissue—atherosclerosis	0.00125	0.0506	CbGeAlD
Tretinoin—ALDH1A1—connective tissue—atherosclerosis	0.00119	0.0479	CbGeAlD
Tretinoin—CRABP2—adipose tissue—atherosclerosis	0.00109	0.0441	CbGeAlD
Tretinoin—RXRG—cardiovascular system—atherosclerosis	0.00108	0.0437	CbGeAlD
Tretinoin—ALDH1A1—cardiovascular system—atherosclerosis	0.00103	0.0417	CbGeAlD
Tretinoin—RXRG—adipose tissue—atherosclerosis	0.000955	0.0386	CbGeAlD
Tretinoin—ALDH1A1—adipose tissue—atherosclerosis	0.000911	0.0368	CbGeAlD
Tretinoin—ALDH1A2—liver—atherosclerosis	0.000878	0.0355	CbGeAlD
Tretinoin—CYP4A11—liver—atherosclerosis	0.000847	0.0342	CbGeAlD
Tretinoin—RARG—adipose tissue—atherosclerosis	0.000797	0.0322	CbGeAlD
Tretinoin—RXRA—liver—atherosclerosis	0.000763	0.0308	CbGeAlD
Tretinoin—RARA—adipose tissue—atherosclerosis	0.00075	0.0303	CbGeAlD
Tretinoin—RARB—liver—atherosclerosis	0.000685	0.0277	CbGeAlD
Tretinoin—ALDH1A1—liver—atherosclerosis	0.000639	0.0258	CbGeAlD
Tretinoin—RXRB—liver—atherosclerosis	0.00063	0.0254	CbGeAlD
Tretinoin—CYP2C18—liver—atherosclerosis	0.000561	0.0227	CbGeAlD
Tretinoin—CYP3A7—liver—atherosclerosis	0.000534	0.0216	CbGeAlD
Tretinoin—CYP2A6—adipose tissue—atherosclerosis	0.000529	0.0214	CbGeAlD
Tretinoin—RARA—liver—atherosclerosis	0.000526	0.0212	CbGeAlD
Tretinoin—CYP3A7-CYP3A51P—liver—atherosclerosis	0.000454	0.0183	CbGeAlD
Tretinoin—CYP2A6—liver—atherosclerosis	0.000371	0.015	CbGeAlD
Tretinoin—CYP2B6—cardiovascular system—atherosclerosis	0.000302	0.0122	CbGeAlD
Tretinoin—CYP2C9—cardiovascular system—atherosclerosis	0.000299	0.0121	CbGeAlD
Tretinoin—CYP1A1—adipose tissue—atherosclerosis	0.000274	0.0111	CbGeAlD
Tretinoin—CYP3A5—adipose tissue—atherosclerosis	0.000268	0.0108	CbGeAlD
Tretinoin—Vision blurred—Lovastatin—atherosclerosis	0.000257	0.00113	CcSEcCtD
Tretinoin—Mental disorder—Simvastatin—atherosclerosis	0.000257	0.00113	CcSEcCtD
Tretinoin—Tremor—Lovastatin—atherosclerosis	0.000256	0.00112	CcSEcCtD
Tretinoin—Visual impairment—Pravastatin—atherosclerosis	0.000256	0.00112	CcSEcCtD
Tretinoin—Erythema—Simvastatin—atherosclerosis	0.000255	0.00112	CcSEcCtD
Tretinoin—Ill-defined disorder—Lovastatin—atherosclerosis	0.000253	0.00111	CcSEcCtD
Tretinoin—Eye disorder—Niacin—atherosclerosis	0.000252	0.0011	CcSEcCtD
Tretinoin—Flatulence—Simvastatin—atherosclerosis	0.000252	0.0011	CcSEcCtD
Tretinoin—Tinnitus—Niacin—atherosclerosis	0.000251	0.0011	CcSEcCtD
Tretinoin—Erythema multiforme—Pravastatin—atherosclerosis	0.000251	0.0011	CcSEcCtD
Tretinoin—Flushing—Niacin—atherosclerosis	0.00025	0.00109	CcSEcCtD
Tretinoin—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000248	0.00109	CcSEcCtD
Tretinoin—Anaemia—Ezetimibe—atherosclerosis	0.000247	0.00108	CcSEcCtD
Tretinoin—Tinnitus—Pravastatin—atherosclerosis	0.000247	0.00108	CcSEcCtD
Tretinoin—Malaise—Lovastatin—atherosclerosis	0.000246	0.00108	CcSEcCtD
Tretinoin—Flushing—Pravastatin—atherosclerosis	0.000246	0.00108	CcSEcCtD
Tretinoin—Angiopathy—Niacin—atherosclerosis	0.000244	0.00107	CcSEcCtD
Tretinoin—Chills—Niacin—atherosclerosis	0.000242	0.00106	CcSEcCtD
Tretinoin—Malaise—Ezetimibe—atherosclerosis	0.000241	0.00106	CcSEcCtD
Tretinoin—Vision blurred—Simvastatin—atherosclerosis	0.000241	0.00105	CcSEcCtD
Tretinoin—Arrhythmia—Niacin—atherosclerosis	0.000241	0.00105	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000239	0.00105	CcSEcCtD
Tretinoin—Tremor—Simvastatin—atherosclerosis	0.000239	0.00105	CcSEcCtD
Tretinoin—Alopecia—Niacin—atherosclerosis	0.000238	0.00104	CcSEcCtD
Tretinoin—Chills—Pravastatin—atherosclerosis	0.000238	0.00104	CcSEcCtD
Tretinoin—Insomnia—Rosuvastatin—atherosclerosis	0.000238	0.00104	CcSEcCtD
Tretinoin—Ill-defined disorder—Simvastatin—atherosclerosis	0.000237	0.00104	CcSEcCtD
Tretinoin—Arrhythmia—Pravastatin—atherosclerosis	0.000237	0.00104	CcSEcCtD
Tretinoin—Palpitations—Ezetimibe—atherosclerosis	0.000237	0.00104	CcSEcCtD
Tretinoin—Paraesthesia—Rosuvastatin—atherosclerosis	0.000236	0.00103	CcSEcCtD
Tretinoin—Anaemia—Simvastatin—atherosclerosis	0.000236	0.00103	CcSEcCtD
Tretinoin—Erythema—Niacin—atherosclerosis	0.000234	0.00103	CcSEcCtD
Tretinoin—Malnutrition—Niacin—atherosclerosis	0.000234	0.00103	CcSEcCtD
Tretinoin—Alopecia—Pravastatin—atherosclerosis	0.000234	0.00103	CcSEcCtD
Tretinoin—Cough—Ezetimibe—atherosclerosis	0.000234	0.00102	CcSEcCtD
Tretinoin—Chest pain—Lovastatin—atherosclerosis	0.000232	0.00102	CcSEcCtD
Tretinoin—Arthralgia—Lovastatin—atherosclerosis	0.000232	0.00102	CcSEcCtD
Tretinoin—Myalgia—Lovastatin—atherosclerosis	0.000232	0.00102	CcSEcCtD
Tretinoin—Anxiety—Lovastatin—atherosclerosis	0.000232	0.00101	CcSEcCtD
Tretinoin—Dyspepsia—Rosuvastatin—atherosclerosis	0.000231	0.00101	CcSEcCtD
Tretinoin—Hypertension—Ezetimibe—atherosclerosis	0.000231	0.00101	CcSEcCtD
Tretinoin—Flatulence—Niacin—atherosclerosis	0.000231	0.00101	CcSEcCtD
Tretinoin—Malaise—Simvastatin—atherosclerosis	0.00023	0.00101	CcSEcCtD
Tretinoin—Tension—Niacin—atherosclerosis	0.00023	0.00101	CcSEcCtD
Tretinoin—Discomfort—Lovastatin—atherosclerosis	0.00023	0.00101	CcSEcCtD
Tretinoin—Myalgia—Ezetimibe—atherosclerosis	0.000228	0.000998	CcSEcCtD
Tretinoin—Arthralgia—Ezetimibe—atherosclerosis	0.000228	0.000998	CcSEcCtD
Tretinoin—Chest pain—Ezetimibe—atherosclerosis	0.000228	0.000998	CcSEcCtD
Tretinoin—Nervousness—Niacin—atherosclerosis	0.000228	0.000997	CcSEcCtD
Tretinoin—Flatulence—Pravastatin—atherosclerosis	0.000227	0.000996	CcSEcCtD
Tretinoin—Dry mouth—Lovastatin—atherosclerosis	0.000227	0.000995	CcSEcCtD
Tretinoin—Tension—Pravastatin—atherosclerosis	0.000227	0.000992	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000226	0.000991	CcSEcCtD
Tretinoin—Discomfort—Ezetimibe—atherosclerosis	0.000225	0.000986	CcSEcCtD
Tretinoin—Pain—Rosuvastatin—atherosclerosis	0.000225	0.000985	CcSEcCtD
Tretinoin—Constipation—Rosuvastatin—atherosclerosis	0.000225	0.000985	CcSEcCtD
Tretinoin—Confusional state—Lovastatin—atherosclerosis	0.000225	0.000984	CcSEcCtD
Tretinoin—Nervousness—Pravastatin—atherosclerosis	0.000224	0.000982	CcSEcCtD
Tretinoin—Dry mouth—Ezetimibe—atherosclerosis	0.000223	0.000976	CcSEcCtD
Tretinoin—Anaphylactic shock—Lovastatin—atherosclerosis	0.000223	0.000976	CcSEcCtD
Tretinoin—Infection—Lovastatin—atherosclerosis	0.000221	0.000969	CcSEcCtD
Tretinoin—Vision blurred—Niacin—atherosclerosis	0.000221	0.000968	CcSEcCtD
Tretinoin—Confusional state—Ezetimibe—atherosclerosis	0.00022	0.000965	CcSEcCtD
Tretinoin—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000218	0.000957	CcSEcCtD
Tretinoin—Thrombocytopenia—Lovastatin—atherosclerosis	0.000218	0.000955	CcSEcCtD
Tretinoin—Vision blurred—Pravastatin—atherosclerosis	0.000218	0.000953	CcSEcCtD
Tretinoin—Arthralgia—Simvastatin—atherosclerosis	0.000217	0.000952	CcSEcCtD
Tretinoin—Myalgia—Simvastatin—atherosclerosis	0.000217	0.000952	CcSEcCtD
Tretinoin—Chest pain—Simvastatin—atherosclerosis	0.000217	0.000952	CcSEcCtD
Tretinoin—Infection—Ezetimibe—atherosclerosis	0.000217	0.000951	CcSEcCtD
Tretinoin—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000217	0.000949	CcSEcCtD
Tretinoin—Anxiety—Simvastatin—atherosclerosis	0.000217	0.000949	CcSEcCtD
Tretinoin—Tremor—Pravastatin—atherosclerosis	0.000216	0.000947	CcSEcCtD
Tretinoin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000215	0.000941	CcSEcCtD
Tretinoin—Discomfort—Simvastatin—atherosclerosis	0.000215	0.000941	CcSEcCtD
Tretinoin—Nervous system disorder—Ezetimibe—atherosclerosis	0.000214	0.000938	CcSEcCtD
Tretinoin—Ill-defined disorder—Pravastatin—atherosclerosis	0.000214	0.000938	CcSEcCtD
Tretinoin—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000214	0.000937	CcSEcCtD
Tretinoin—Anaemia—Pravastatin—atherosclerosis	0.000213	0.000934	CcSEcCtD
Tretinoin—Anorexia—Lovastatin—atherosclerosis	0.000212	0.00093	CcSEcCtD
Tretinoin—Skin disorder—Ezetimibe—atherosclerosis	0.000212	0.00093	CcSEcCtD
Tretinoin—Syncope—Niacin—atherosclerosis	0.00021	0.000921	CcSEcCtD
Tretinoin—Confusional state—Simvastatin—atherosclerosis	0.00021	0.00092	CcSEcCtD
Tretinoin—Urticaria—Rosuvastatin—atherosclerosis	0.000209	0.000915	CcSEcCtD
Tretinoin—Anaphylactic shock—Simvastatin—atherosclerosis	0.000208	0.000913	CcSEcCtD
Tretinoin—Oedema—Simvastatin—atherosclerosis	0.000208	0.000913	CcSEcCtD
Tretinoin—CYP2C8—liver—atherosclerosis	0.000208	0.00841	CbGeAlD
Tretinoin—Malaise—Pravastatin—atherosclerosis	0.000208	0.000912	CcSEcCtD
Tretinoin—Abdominal pain—Rosuvastatin—atherosclerosis	0.000208	0.00091	CcSEcCtD
Tretinoin—Palpitations—Niacin—atherosclerosis	0.000207	0.000907	CcSEcCtD
Tretinoin—Infection—Simvastatin—atherosclerosis	0.000207	0.000907	CcSEcCtD
Tretinoin—Loss of consciousness—Niacin—atherosclerosis	0.000206	0.000902	CcSEcCtD
Tretinoin—Cough—Niacin—atherosclerosis	0.000205	0.000896	CcSEcCtD
Tretinoin—Thrombocytopenia—Simvastatin—atherosclerosis	0.000204	0.000894	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000203	0.000889	CcSEcCtD
Tretinoin—Insomnia—Lovastatin—atherosclerosis	0.000201	0.000882	CcSEcCtD
Tretinoin—Cough—Pravastatin—atherosclerosis	0.000201	0.000882	CcSEcCtD
Tretinoin—Paraesthesia—Lovastatin—atherosclerosis	0.0002	0.000876	CcSEcCtD
Tretinoin—Myalgia—Niacin—atherosclerosis	0.0002	0.000874	CcSEcCtD
Tretinoin—Arthralgia—Niacin—atherosclerosis	0.0002	0.000874	CcSEcCtD
Tretinoin—Hypertension—Pravastatin—atherosclerosis	0.000199	0.000873	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000199	0.000872	CcSEcCtD
Tretinoin—Anorexia—Simvastatin—atherosclerosis	0.000199	0.00087	CcSEcCtD
Tretinoin—Dyspnoea—Lovastatin—atherosclerosis	0.000199	0.00087	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000198	0.000868	CcSEcCtD
Tretinoin—Insomnia—Ezetimibe—atherosclerosis	0.000198	0.000866	CcSEcCtD
Tretinoin—Arthralgia—Pravastatin—atherosclerosis	0.000197	0.000861	CcSEcCtD
Tretinoin—Chest pain—Pravastatin—atherosclerosis	0.000197	0.000861	CcSEcCtD
Tretinoin—Myalgia—Pravastatin—atherosclerosis	0.000197	0.000861	CcSEcCtD
Tretinoin—Paraesthesia—Ezetimibe—atherosclerosis	0.000196	0.000859	CcSEcCtD
Tretinoin—Dyspepsia—Lovastatin—atherosclerosis	0.000196	0.000859	CcSEcCtD
Tretinoin—Anxiety—Pravastatin—atherosclerosis	0.000196	0.000858	CcSEcCtD
Tretinoin—Dry mouth—Niacin—atherosclerosis	0.000195	0.000855	CcSEcCtD
Tretinoin—Dyspnoea—Ezetimibe—atherosclerosis	0.000195	0.000853	CcSEcCtD
Tretinoin—Discomfort—Pravastatin—atherosclerosis	0.000194	0.00085	CcSEcCtD
Tretinoin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000194	0.000848	CcSEcCtD
Tretinoin—Decreased appetite—Lovastatin—atherosclerosis	0.000194	0.000848	CcSEcCtD
Tretinoin—Dyspepsia—Ezetimibe—atherosclerosis	0.000192	0.000842	CcSEcCtD
Tretinoin—CYP1A1—liver—atherosclerosis	0.000192	0.00776	CbGeAlD
Tretinoin—Fatigue—Lovastatin—atherosclerosis	0.000192	0.000841	CcSEcCtD
Tretinoin—Anaphylactic shock—Niacin—atherosclerosis	0.000191	0.000838	CcSEcCtD
Tretinoin—Oedema—Niacin—atherosclerosis	0.000191	0.000838	CcSEcCtD
Tretinoin—Constipation—Lovastatin—atherosclerosis	0.000191	0.000834	CcSEcCtD
Tretinoin—Pain—Lovastatin—atherosclerosis	0.000191	0.000834	CcSEcCtD
Tretinoin—Confusional state—Pravastatin—atherosclerosis	0.00019	0.000832	CcSEcCtD
Tretinoin—Decreased appetite—Ezetimibe—atherosclerosis	0.00019	0.000832	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00019	0.000831	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000189	0.000826	CcSEcCtD
Tretinoin—Asthenia—Rosuvastatin—atherosclerosis	0.000189	0.000826	CcSEcCtD
Tretinoin—Insomnia—Simvastatin—atherosclerosis	0.000188	0.000825	CcSEcCtD
Tretinoin—Oedema—Pravastatin—atherosclerosis	0.000188	0.000825	CcSEcCtD
Tretinoin—Anaphylactic shock—Pravastatin—atherosclerosis	0.000188	0.000825	CcSEcCtD
Tretinoin—Fatigue—Ezetimibe—atherosclerosis	0.000188	0.000825	CcSEcCtD
Tretinoin—Shock—Niacin—atherosclerosis	0.000188	0.000824	CcSEcCtD
Tretinoin—CYP3A5—liver—atherosclerosis	0.000188	0.00759	CbGeAlD
Tretinoin—Infection—Pravastatin—atherosclerosis	0.000187	0.00082	CcSEcCtD
Tretinoin—Paraesthesia—Simvastatin—atherosclerosis	0.000187	0.000819	CcSEcCtD
Tretinoin—Constipation—Ezetimibe—atherosclerosis	0.000187	0.000818	CcSEcCtD
Tretinoin—Pain—Ezetimibe—atherosclerosis	0.000187	0.000818	CcSEcCtD
Tretinoin—CYP2B6—liver—atherosclerosis	0.000187	0.00754	CbGeAlD
Tretinoin—Tachycardia—Niacin—atherosclerosis	0.000187	0.000818	CcSEcCtD
Tretinoin—Pruritus—Rosuvastatin—atherosclerosis	0.000186	0.000815	CcSEcCtD
Tretinoin—Skin disorder—Niacin—atherosclerosis	0.000186	0.000814	CcSEcCtD
Tretinoin—Dyspnoea—Simvastatin—atherosclerosis	0.000186	0.000814	CcSEcCtD
Tretinoin—CYP2C9—liver—atherosclerosis	0.000185	0.00747	CbGeAlD
Tretinoin—Hyperhidrosis—Niacin—atherosclerosis	0.000185	0.00081	CcSEcCtD
Tretinoin—Thrombocytopenia—Pravastatin—atherosclerosis	0.000184	0.000808	CcSEcCtD
Tretinoin—Feeling abnormal—Lovastatin—atherosclerosis	0.000184	0.000804	CcSEcCtD
Tretinoin—Dyspepsia—Simvastatin—atherosclerosis	0.000183	0.000803	CcSEcCtD
Tretinoin—Anorexia—Niacin—atherosclerosis	0.000182	0.000799	CcSEcCtD
Tretinoin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000182	0.000798	CcSEcCtD
Tretinoin—Hyperhidrosis—Pravastatin—atherosclerosis	0.000182	0.000798	CcSEcCtD
Tretinoin—Decreased appetite—Simvastatin—atherosclerosis	0.000181	0.000793	CcSEcCtD
Tretinoin—Feeling abnormal—Ezetimibe—atherosclerosis	0.00018	0.000789	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00018	0.000788	CcSEcCtD
Tretinoin—Diarrhoea—Rosuvastatin—atherosclerosis	0.00018	0.000788	CcSEcCtD
Tretinoin—Fatigue—Simvastatin—atherosclerosis	0.00018	0.000787	CcSEcCtD
Tretinoin—Anorexia—Pravastatin—atherosclerosis	0.00018	0.000786	CcSEcCtD
Tretinoin—Hypotension—Niacin—atherosclerosis	0.000179	0.000783	CcSEcCtD
Tretinoin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000179	0.000783	CcSEcCtD
Tretinoin—Pain—Simvastatin—atherosclerosis	0.000178	0.00078	CcSEcCtD
Tretinoin—Constipation—Simvastatin—atherosclerosis	0.000178	0.00078	CcSEcCtD
Tretinoin—Urticaria—Lovastatin—atherosclerosis	0.000177	0.000775	CcSEcCtD
Tretinoin—Abdominal pain—Lovastatin—atherosclerosis	0.000176	0.000771	CcSEcCtD
Tretinoin—Body temperature increased—Lovastatin—atherosclerosis	0.000176	0.000771	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000174	0.000763	CcSEcCtD
Tretinoin—Dizziness—Rosuvastatin—atherosclerosis	0.000174	0.000761	CcSEcCtD
Tretinoin—Urticaria—Ezetimibe—atherosclerosis	0.000174	0.00076	CcSEcCtD
Tretinoin—Insomnia—Niacin—atherosclerosis	0.000173	0.000758	CcSEcCtD
Tretinoin—Abdominal pain—Ezetimibe—atherosclerosis	0.000173	0.000757	CcSEcCtD
Tretinoin—Body temperature increased—Ezetimibe—atherosclerosis	0.000173	0.000757	CcSEcCtD
Tretinoin—Paraesthesia—Niacin—atherosclerosis	0.000172	0.000752	CcSEcCtD
Tretinoin—Feeling abnormal—Simvastatin—atherosclerosis	0.000172	0.000752	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000172	0.000752	CcSEcCtD
Tretinoin—Dyspnoea—Niacin—atherosclerosis	0.000171	0.000747	CcSEcCtD
Tretinoin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00017	0.000746	CcSEcCtD
Tretinoin—Insomnia—Pravastatin—atherosclerosis	0.00017	0.000746	CcSEcCtD
Tretinoin—Somnolence—Niacin—atherosclerosis	0.00017	0.000745	CcSEcCtD
Tretinoin—Paraesthesia—Pravastatin—atherosclerosis	0.000169	0.000741	CcSEcCtD
Tretinoin—Dyspepsia—Niacin—atherosclerosis	0.000168	0.000738	CcSEcCtD
Tretinoin—Dyspnoea—Pravastatin—atherosclerosis	0.000168	0.000736	CcSEcCtD
Tretinoin—Decreased appetite—Niacin—atherosclerosis	0.000166	0.000728	CcSEcCtD
Tretinoin—Dyspepsia—Pravastatin—atherosclerosis	0.000166	0.000726	CcSEcCtD
Tretinoin—Rash—Rosuvastatin—atherosclerosis	0.000166	0.000726	CcSEcCtD
Tretinoin—Dermatitis—Rosuvastatin—atherosclerosis	0.000166	0.000725	CcSEcCtD
Tretinoin—Urticaria—Simvastatin—atherosclerosis	0.000166	0.000725	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Niacin—atherosclerosis	0.000165	0.000723	CcSEcCtD
Tretinoin—Body temperature increased—Simvastatin—atherosclerosis	0.000165	0.000721	CcSEcCtD
Tretinoin—Abdominal pain—Simvastatin—atherosclerosis	0.000165	0.000721	CcSEcCtD
Tretinoin—Headache—Rosuvastatin—atherosclerosis	0.000165	0.000721	CcSEcCtD
Tretinoin—Hypersensitivity—Lovastatin—atherosclerosis	0.000164	0.000719	CcSEcCtD
Tretinoin—Decreased appetite—Pravastatin—atherosclerosis	0.000164	0.000717	CcSEcCtD
Tretinoin—Pain—Niacin—atherosclerosis	0.000164	0.000717	CcSEcCtD
Tretinoin—Fatigue—Pravastatin—atherosclerosis	0.000162	0.000711	CcSEcCtD
Tretinoin—Pain—Pravastatin—atherosclerosis	0.000161	0.000706	CcSEcCtD
Tretinoin—Constipation—Pravastatin—atherosclerosis	0.000161	0.000706	CcSEcCtD
Tretinoin—Hypersensitivity—Ezetimibe—atherosclerosis	0.000161	0.000705	CcSEcCtD
Tretinoin—Asthenia—Lovastatin—atherosclerosis	0.00016	0.0007	CcSEcCtD
Tretinoin—Pruritus—Lovastatin—atherosclerosis	0.000158	0.00069	CcSEcCtD
Tretinoin—Asthenia—Ezetimibe—atherosclerosis	0.000157	0.000687	CcSEcCtD
Tretinoin—Gastrointestinal pain—Niacin—atherosclerosis	0.000156	0.000685	CcSEcCtD
Tretinoin—Nausea—Rosuvastatin—atherosclerosis	0.000156	0.000684	CcSEcCtD
Tretinoin—Feeling abnormal—Pravastatin—atherosclerosis	0.000155	0.00068	CcSEcCtD
Tretinoin—Pruritus—Ezetimibe—atherosclerosis	0.000155	0.000677	CcSEcCtD
Tretinoin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000154	0.000675	CcSEcCtD
Tretinoin—Hypersensitivity—Simvastatin—atherosclerosis	0.000154	0.000672	CcSEcCtD
Tretinoin—Diarrhoea—Lovastatin—atherosclerosis	0.000152	0.000668	CcSEcCtD
Tretinoin—Urticaria—Niacin—atherosclerosis	0.000152	0.000666	CcSEcCtD
Tretinoin—Abdominal pain—Niacin—atherosclerosis	0.000151	0.000662	CcSEcCtD
Tretinoin—Body temperature increased—Niacin—atherosclerosis	0.000151	0.000662	CcSEcCtD
Tretinoin—Urticaria—Pravastatin—atherosclerosis	0.00015	0.000655	CcSEcCtD
Tretinoin—Asthenia—Simvastatin—atherosclerosis	0.00015	0.000655	CcSEcCtD
Tretinoin—Diarrhoea—Ezetimibe—atherosclerosis	0.000149	0.000655	CcSEcCtD
Tretinoin—Abdominal pain—Pravastatin—atherosclerosis	0.000149	0.000652	CcSEcCtD
Tretinoin—Body temperature increased—Pravastatin—atherosclerosis	0.000149	0.000652	CcSEcCtD
Tretinoin—Pruritus—Simvastatin—atherosclerosis	0.000147	0.000646	CcSEcCtD
Tretinoin—Dizziness—Lovastatin—atherosclerosis	0.000147	0.000645	CcSEcCtD
Tretinoin—Dizziness—Ezetimibe—atherosclerosis	0.000144	0.000633	CcSEcCtD
Tretinoin—Diarrhoea—Simvastatin—atherosclerosis	0.000143	0.000624	CcSEcCtD
Tretinoin—Vomiting—Lovastatin—atherosclerosis	0.000142	0.00062	CcSEcCtD
Tretinoin—CYP3A4—liver—atherosclerosis	0.000141	0.00569	CbGeAlD
Tretinoin—Hypersensitivity—Niacin—atherosclerosis	0.000141	0.000617	CcSEcCtD
Tretinoin—Rash—Lovastatin—atherosclerosis	0.00014	0.000615	CcSEcCtD
Tretinoin—Dermatitis—Lovastatin—atherosclerosis	0.00014	0.000615	CcSEcCtD
Tretinoin—Headache—Lovastatin—atherosclerosis	0.00014	0.000611	CcSEcCtD
Tretinoin—Vomiting—Ezetimibe—atherosclerosis	0.000139	0.000608	CcSEcCtD
Tretinoin—Hypersensitivity—Pravastatin—atherosclerosis	0.000139	0.000608	CcSEcCtD
Tretinoin—Dizziness—Simvastatin—atherosclerosis	0.000138	0.000603	CcSEcCtD
Tretinoin—Rash—Ezetimibe—atherosclerosis	0.000138	0.000603	CcSEcCtD
Tretinoin—Dermatitis—Ezetimibe—atherosclerosis	0.000138	0.000603	CcSEcCtD
Tretinoin—Asthenia—Niacin—atherosclerosis	0.000137	0.000601	CcSEcCtD
Tretinoin—Headache—Ezetimibe—atherosclerosis	0.000137	0.0006	CcSEcCtD
Tretinoin—Pruritus—Niacin—atherosclerosis	0.000135	0.000593	CcSEcCtD
Tretinoin—Asthenia—Pravastatin—atherosclerosis	0.000135	0.000592	CcSEcCtD
Tretinoin—Pruritus—Pravastatin—atherosclerosis	0.000133	0.000584	CcSEcCtD
Tretinoin—Vomiting—Simvastatin—atherosclerosis	0.000132	0.00058	CcSEcCtD
Tretinoin—Nausea—Lovastatin—atherosclerosis	0.000132	0.00058	CcSEcCtD
Tretinoin—Rash—Simvastatin—atherosclerosis	0.000131	0.000575	CcSEcCtD
Tretinoin—Dermatitis—Simvastatin—atherosclerosis	0.000131	0.000575	CcSEcCtD
Tretinoin—Diarrhoea—Niacin—atherosclerosis	0.000131	0.000573	CcSEcCtD
Tretinoin—Headache—Simvastatin—atherosclerosis	0.000131	0.000572	CcSEcCtD
Tretinoin—Nausea—Ezetimibe—atherosclerosis	0.00013	0.000568	CcSEcCtD
Tretinoin—Diarrhoea—Pravastatin—atherosclerosis	0.000129	0.000565	CcSEcCtD
Tretinoin—Dizziness—Niacin—atherosclerosis	0.000127	0.000554	CcSEcCtD
Tretinoin—Dizziness—Pravastatin—atherosclerosis	0.000125	0.000546	CcSEcCtD
Tretinoin—Nausea—Simvastatin—atherosclerosis	0.000124	0.000542	CcSEcCtD
Tretinoin—Vomiting—Niacin—atherosclerosis	0.000122	0.000533	CcSEcCtD
Tretinoin—Rash—Niacin—atherosclerosis	0.000121	0.000528	CcSEcCtD
Tretinoin—Dermatitis—Niacin—atherosclerosis	0.000121	0.000528	CcSEcCtD
Tretinoin—Headache—Niacin—atherosclerosis	0.00012	0.000525	CcSEcCtD
Tretinoin—Vomiting—Pravastatin—atherosclerosis	0.00012	0.000525	CcSEcCtD
Tretinoin—Rash—Pravastatin—atherosclerosis	0.000119	0.00052	CcSEcCtD
Tretinoin—Dermatitis—Pravastatin—atherosclerosis	0.000119	0.00052	CcSEcCtD
Tretinoin—Headache—Pravastatin—atherosclerosis	0.000118	0.000517	CcSEcCtD
Tretinoin—Nausea—Niacin—atherosclerosis	0.000114	0.000498	CcSEcCtD
Tretinoin—Nausea—Pravastatin—atherosclerosis	0.000112	0.00049	CcSEcCtD
Tretinoin—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	6.63e-06	3.33e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	6.63e-06	3.33e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALOX15—atherosclerosis	6.63e-06	3.33e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PPARG—atherosclerosis	6.61e-06	3.31e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—SCARB1—atherosclerosis	6.59e-06	3.3e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—HMOX1—atherosclerosis	6.58e-06	3.3e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ABCG5—atherosclerosis	6.55e-06	3.28e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	6.54e-06	3.28e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—NOS3—atherosclerosis	6.5e-06	3.26e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CETP—atherosclerosis	6.5e-06	3.26e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—INS—atherosclerosis	6.48e-06	3.25e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—IL6—atherosclerosis	6.46e-06	3.24e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	6.4e-06	3.21e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—HMGCR—atherosclerosis	6.36e-06	3.19e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—LPA—atherosclerosis	6.32e-06	3.17e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—APOB—atherosclerosis	6.3e-06	3.16e-05	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—AKT1—atherosclerosis	6.22e-06	3.12e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—SCARB1—atherosclerosis	6.22e-06	3.12e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—HMGCR—atherosclerosis	6.22e-06	3.12e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CG—atherosclerosis	6.21e-06	3.12e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—NAMPT—atherosclerosis	6.21e-06	3.12e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	6.18e-06	3.1e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—LIPC—atherosclerosis	6.17e-06	3.1e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—APOC3—atherosclerosis	6.14e-06	3.08e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GSTM1—atherosclerosis	6.13e-06	3.07e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—BGN—atherosclerosis	6.13e-06	3.07e-05	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—AKT1—atherosclerosis	6.1e-06	3.06e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—LDLR—atherosclerosis	6.1e-06	3.06e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	6.08e-06	3.05e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—APOA5—atherosclerosis	6.06e-06	3.04e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	6.06e-06	3.04e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—HMOX1—atherosclerosis	6.03e-06	3.02e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—LPL—atherosclerosis	6.02e-06	3.02e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PPARG—atherosclerosis	6e-06	3.01e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—AKT1—atherosclerosis	5.96e-06	2.99e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CETP—atherosclerosis	5.96e-06	2.99e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PTGS2—atherosclerosis	5.95e-06	2.98e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—ALB—atherosclerosis	5.94e-06	2.98e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	5.89e-06	2.95e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—INS—atherosclerosis	5.88e-06	2.95e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—HMGCR—atherosclerosis	5.88e-06	2.95e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GPX1—atherosclerosis	5.87e-06	2.94e-05	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—AKT1—atherosclerosis	5.85e-06	2.93e-05	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—AKT1—atherosclerosis	5.85e-06	2.93e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	5.84e-06	2.93e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—APOB—atherosclerosis	5.78e-06	2.9e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	5.77e-06	2.89e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	5.72e-06	2.87e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CD36—atherosclerosis	5.72e-06	2.87e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	5.7e-06	2.86e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—SCARB1—atherosclerosis	5.7e-06	2.86e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—NOS3—atherosclerosis	5.68e-06	2.85e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ABCA1—atherosclerosis	5.67e-06	2.84e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALOX5—atherosclerosis	5.64e-06	2.83e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GSTM1—atherosclerosis	5.62e-06	2.82e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	5.55e-06	2.79e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ABCA1—atherosclerosis	5.54e-06	2.78e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—LPL—atherosclerosis	5.52e-06	2.77e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ABCG1—atherosclerosis	5.5e-06	2.76e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—MTHFR—atherosclerosis	5.42e-06	2.72e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—ALB—atherosclerosis	5.39e-06	2.7e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—HMGCR—atherosclerosis	5.39e-06	2.7e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GPX1—atherosclerosis	5.38e-06	2.7e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PPARA—atherosclerosis	5.31e-06	2.67e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.3e-06	2.66e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CD36—atherosclerosis	5.24e-06	2.63e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ABCA1—atherosclerosis	5.24e-06	2.63e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	5.21e-06	2.61e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PTGS2—atherosclerosis	5.2e-06	2.61e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—LCAT—atherosclerosis	5.17e-06	2.6e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—FABP4—atherosclerosis	5.17e-06	2.6e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—NOS3—atherosclerosis	5.16e-06	2.59e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—AGT—atherosclerosis	5.15e-06	2.58e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—APOA4—atherosclerosis	5.08e-06	2.55e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NAMPT—atherosclerosis	5.06e-06	2.54e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—APOE—atherosclerosis	5.04e-06	2.53e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.03e-06	2.52e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—LIPC—atherosclerosis	5.02e-06	2.52e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CAV1—atherosclerosis	5e-06	2.51e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—APOC3—atherosclerosis	4.99e-06	2.5e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP7A1—atherosclerosis	4.99e-06	2.5e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—APOA1—atherosclerosis	4.99e-06	2.5e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—MTHFR—atherosclerosis	4.97e-06	2.49e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—LDLR—atherosclerosis	4.96e-06	2.49e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PPARA—atherosclerosis	4.87e-06	2.44e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—HMOX1—atherosclerosis	4.87e-06	2.44e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.86e-06	2.44e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CETP—atherosclerosis	4.85e-06	2.43e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ABCA1—atherosclerosis	4.8e-06	2.41e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—HMOX1—atherosclerosis	4.76e-06	2.39e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—AGT—atherosclerosis	4.72e-06	2.37e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTGS2—atherosclerosis	4.72e-06	2.37e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—APOB—atherosclerosis	4.66e-06	2.34e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SCARB1—atherosclerosis	4.64e-06	2.33e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—APOE—atherosclerosis	4.62e-06	2.32e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP27A1—atherosclerosis	4.61e-06	2.31e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CAV1—atherosclerosis	4.58e-06	2.3e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—APOA1—atherosclerosis	4.57e-06	2.29e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—APOB—atherosclerosis	4.56e-06	2.28e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CG—atherosclerosis	4.55e-06	2.28e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GSTM1—atherosclerosis	4.53e-06	2.27e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—MAPK3—atherosclerosis	4.52e-06	2.27e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.52e-06	2.27e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—HMOX1—atherosclerosis	4.49e-06	2.25e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—LPL—atherosclerosis	4.45e-06	2.23e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GSTM1—atherosclerosis	4.43e-06	2.22e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PPARG—atherosclerosis	4.39e-06	2.2e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—HMGCR—atherosclerosis	4.38e-06	2.2e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	4.37e-06	2.19e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALOX15—atherosclerosis	4.37e-06	2.19e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—APOA2—atherosclerosis	4.37e-06	2.19e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	4.37e-06	2.19e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—LPL—atherosclerosis	4.35e-06	2.18e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GPX1—atherosclerosis	4.34e-06	2.18e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ABCG5—atherosclerosis	4.32e-06	2.17e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—INS—atherosclerosis	4.31e-06	2.16e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—APOB—atherosclerosis	4.3e-06	2.16e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GPX1—atherosclerosis	4.24e-06	2.13e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CD36—atherosclerosis	4.23e-06	2.12e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GSTM1—atherosclerosis	4.19e-06	2.1e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CG—atherosclerosis	4.17e-06	2.09e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—LPA—atherosclerosis	4.17e-06	2.09e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CD36—atherosclerosis	4.13e-06	2.07e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—HMOX1—atherosclerosis	4.12e-06	2.07e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—LPL—atherosclerosis	4.11e-06	2.06e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—BGN—atherosclerosis	4.04e-06	2.03e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PPARG—atherosclerosis	4.03e-06	2.02e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GPX1—atherosclerosis	4.01e-06	2.01e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—MTHFR—atherosclerosis	4.01e-06	2.01e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—APOA5—atherosclerosis	4e-06	2.01e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.95e-06	1.98e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ALB—atherosclerosis	3.95e-06	1.98e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—INS—atherosclerosis	3.95e-06	1.98e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—APOB—atherosclerosis	3.95e-06	1.98e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PPARA—atherosclerosis	3.93e-06	1.97e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—MTHFR—atherosclerosis	3.92e-06	1.96e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ABCA1—atherosclerosis	3.91e-06	1.96e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CD36—atherosclerosis	3.9e-06	1.96e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	3.85e-06	1.93e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PPARA—atherosclerosis	3.84e-06	1.93e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GSTM1—atherosclerosis	3.84e-06	1.93e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—AGT—atherosclerosis	3.81e-06	1.91e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—NOS3—atherosclerosis	3.78e-06	1.9e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—LPL—atherosclerosis	3.77e-06	1.89e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—APOE—atherosclerosis	3.73e-06	1.87e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—AGT—atherosclerosis	3.72e-06	1.87e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALOX5—atherosclerosis	3.72e-06	1.86e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—MTHFR—atherosclerosis	3.7e-06	1.86e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CAV1—atherosclerosis	3.7e-06	1.85e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—APOA1—atherosclerosis	3.69e-06	1.85e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GPX1—atherosclerosis	3.68e-06	1.84e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—APOE—atherosclerosis	3.65e-06	1.83e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PPARA—atherosclerosis	3.63e-06	1.82e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ALB—atherosclerosis	3.62e-06	1.82e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CAV1—atherosclerosis	3.61e-06	1.81e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—APOA1—atherosclerosis	3.6e-06	1.81e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CD36—atherosclerosis	3.58e-06	1.8e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—AGT—atherosclerosis	3.52e-06	1.76e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—NOS3—atherosclerosis	3.46e-06	1.74e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTGS2—atherosclerosis	3.46e-06	1.73e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—APOE—atherosclerosis	3.44e-06	1.73e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CAV1—atherosclerosis	3.41e-06	1.71e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—APOA1—atherosclerosis	3.4e-06	1.71e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—MTHFR—atherosclerosis	3.39e-06	1.7e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CG—atherosclerosis	3.37e-06	1.69e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—HMOX1—atherosclerosis	3.35e-06	1.68e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NAMPT—atherosclerosis	3.33e-06	1.67e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PPARA—atherosclerosis	3.33e-06	1.67e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—LIPC—atherosclerosis	3.31e-06	1.66e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—APOC3—atherosclerosis	3.29e-06	1.65e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CG—atherosclerosis	3.29e-06	1.65e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—LDLR—atherosclerosis	3.27e-06	1.64e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PPARG—atherosclerosis	3.25e-06	1.63e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—AGT—atherosclerosis	3.22e-06	1.62e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—APOB—atherosclerosis	3.21e-06	1.61e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CETP—atherosclerosis	3.2e-06	1.6e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—INS—atherosclerosis	3.19e-06	1.6e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PPARG—atherosclerosis	3.18e-06	1.59e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTGS2—atherosclerosis	3.17e-06	1.59e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—APOE—atherosclerosis	3.16e-06	1.58e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CAV1—atherosclerosis	3.13e-06	1.57e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTM1—atherosclerosis	3.12e-06	1.57e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—APOA1—atherosclerosis	3.12e-06	1.57e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—INS—atherosclerosis	3.11e-06	1.56e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CG—atherosclerosis	3.11e-06	1.56e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—LPL—atherosclerosis	3.07e-06	1.54e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SCARB1—atherosclerosis	3.06e-06	1.54e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—AKT1—atherosclerosis	3.05e-06	1.53e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PPARG—atherosclerosis	3e-06	1.5e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GPX1—atherosclerosis	2.99e-06	1.5e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—AKT1—atherosclerosis	2.99e-06	1.5e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—INS—atherosclerosis	2.94e-06	1.48e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ALB—atherosclerosis	2.92e-06	1.47e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CD36—atherosclerosis	2.91e-06	1.46e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HMGCR—atherosclerosis	2.89e-06	1.45e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ALB—atherosclerosis	2.86e-06	1.43e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CG—atherosclerosis	2.85e-06	1.43e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—NOS3—atherosclerosis	2.79e-06	1.4e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—MTHFR—atherosclerosis	2.76e-06	1.38e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PPARG—atherosclerosis	2.75e-06	1.38e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—NOS3—atherosclerosis	2.73e-06	1.37e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PPARA—atherosclerosis	2.71e-06	1.36e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—INS—atherosclerosis	2.7e-06	1.35e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ALB—atherosclerosis	2.7e-06	1.35e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—AGT—atherosclerosis	2.62e-06	1.32e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—AKT1—atherosclerosis	2.61e-06	1.31e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—NOS3—atherosclerosis	2.58e-06	1.29e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.58e-06	1.29e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—APOE—atherosclerosis	2.57e-06	1.29e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTGS2—atherosclerosis	2.56e-06	1.28e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CAV1—atherosclerosis	2.55e-06	1.28e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—APOA1—atherosclerosis	2.54e-06	1.27e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTGS2—atherosclerosis	2.5e-06	1.25e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ALB—atherosclerosis	2.47e-06	1.24e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—AKT1—atherosclerosis	2.37e-06	1.19e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—NOS3—atherosclerosis	2.37e-06	1.19e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTGS2—atherosclerosis	2.36e-06	1.18e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CG—atherosclerosis	2.32e-06	1.16e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PPARG—atherosclerosis	2.24e-06	1.12e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.21e-06	1.11e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—INS—atherosclerosis	2.2e-06	1.1e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTGS2—atherosclerosis	2.16e-06	1.09e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—APOB—atherosclerosis	2.12e-06	1.06e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.06e-06	1.03e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—LPL—atherosclerosis	2.02e-06	1.01e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALB—atherosclerosis	2.01e-06	1.01e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GPX1—atherosclerosis	1.97e-06	9.9e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NOS3—atherosclerosis	1.93e-06	9.66e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CD36—atherosclerosis	1.92e-06	9.64e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.82e-06	9.13e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PPARA—atherosclerosis	1.79e-06	8.96e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTGS2—atherosclerosis	1.76e-06	8.83e-06	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—AKT1—atherosclerosis	1.74e-06	8.71e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—AGT—atherosclerosis	1.73e-06	8.68e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—APOE—atherosclerosis	1.69e-06	8.5e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CAV1—atherosclerosis	1.68e-06	8.42e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—APOA1—atherosclerosis	1.68e-06	8.4e-06	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—AKT1—atherosclerosis	1.59e-06	7.99e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.53e-06	7.67e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PPARG—atherosclerosis	1.48e-06	7.41e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—INS—atherosclerosis	1.45e-06	7.26e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALB—atherosclerosis	1.33e-06	6.66e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—AKT1—atherosclerosis	1.28e-06	6.44e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NOS3—atherosclerosis	1.27e-06	6.37e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—AKT1—atherosclerosis	1.26e-06	6.3e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—AKT1—atherosclerosis	1.19e-06	5.95e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.16e-06	5.83e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—AKT1—atherosclerosis	1.09e-06	5.45e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—AKT1—atherosclerosis	8.85e-07	4.44e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—AKT1—atherosclerosis	5.84e-07	2.93e-06	CbGpPWpGaD
